Pyrazolopyrimidine compounds and uses thereof
Abstract:
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting ALK2 activity and/or FGFR activity, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with ALK2 activity and/or FGFR activity, such as cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0